Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis. - Blaise,D.; Olive,D.; Michallet,M.; Marit,G.; Leblond,V.; Maraninchi,D. (Lancet, 1995)